secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0001459839-24-000061
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q2 revenue $40M (+20% YoY); raises 2024 guidance to $165-167M
---------------------------------------------------------------------

- Revenue $40.0M, up 20% YoY; U.S. revenue $37.8M (+21%). Net loss $8.9M ($0.22 loss per share) improved 20%.
- Adjusted EBITDA loss $2.7M, improved 43% YoY; expects positive adjusted EBITDA in Q4 2024.
- Raises 2024 revenue guidance to $165M-$167M (previous $164M-$166M), implying ~19-20% growth.
- Elected Daniel Wolf to Board of Directors effective Aug 5, 2024; he is SVP Chief Strategy & M&A at Baxter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000061/0001459839-24-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000061/sibn-20240804.htm
  HTML page:      https://secwatch.observer/filing/0001459839-24-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer